ReviewClinical, cosmetic and investigational dermatology2023

Adalimumab, Ustekinumab, and Secukinumab in the Management of Hidradenitis Suppurativa: A Review of the Real-Life Experience.

Fabrizio Martora et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.